Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response ...
As global markets show signs of recovery with major U.S. indexes approaching record highs, investors are increasingly focusing on stable income sources amid geopolitical uncertainties and economic ...